Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BIOSECURE Act
Pharma
Enhertu, ADC trial deaths, Takeda—Fierce Pharma Asia
Enhertu enters first-line treatment. Daiichi paused an ADC trial following patient deaths. Takeda touts a pair of positive TYK2 readouts. Plus more.
Angus Liu
Dec 19, 2025 8:00am
Biosecure Act heads to Trump's desk after Senate vote
Dec 17, 2025 4:45pm
Pfizer-Fosun, Zealand, China's new formulary—Fierce Pharma Asia
Dec 12, 2025 8:15am
Biosecure Act slips into key US defense bill
Dec 9, 2025 11:00am
WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
Dec 4, 2025 8:55am
Licensing deals, AI pact and Novo vs. KBP—Fierce Pharma Asia
Oct 17, 2025 9:40am
